{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:27:25Z","timestamp":1777354045911,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1011153"],"award-info":[{"award-number":["1011153"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"International Cooperation program of Jilin Province","award":["No. 20140414066GH"],"award-info":[{"award-number":["No. 20140414066GH"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12890-019-0786-x","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T08:06:27Z","timestamp":1549526787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis"],"prefix":"10.1186","volume":"19","author":[{"given":"Adam M.","family":"Collison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Pereira","family":"de Siqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejiao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamish D.","family":"Toop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm R.","family":"Starkey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Mattes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"issue":"6","key":"786_CR1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"786_CR2","doi-asserted-by":"publisher","unstructured":"Daccord C, Maher TM. Recent advances in understanding idiopathic pulmonary fibrosis. F1000Res. 2016. \n                    https:\/\/doi.org\/10.12688\/f1000research.8209.1\n                    \n                  . eCollection 2016.","DOI":"10.12688\/f1000research.8209.1"},{"issue":"11","key":"786_CR3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/thx.2006.062836","volume":"61","author":"J Gribbin","year":"2006","unstructured":"Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006;61(11):980\u20135.","journal-title":"Thorax"},{"issue":"9","key":"786_CR4","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1164\/rccm.200709-1446OC","volume":"178","author":"G Raghu","year":"2008","unstructured":"Raghu G, Brown KK, Costabel U, Cottin V, du Bois RM, Lasky JA, Thomeer M, Utz JP, Khandker RK, McDermott L, et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med. 2008;178(9):948\u201355.","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"786_CR5","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083\u201392.","journal-title":"N Engl J Med"},{"issue":"22","key":"786_CR6","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071\u201382.","journal-title":"N Engl J Med"},{"issue":"11","key":"786_CR7","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/nm1660","volume":"13","author":"M Weckmann","year":"2007","unstructured":"Weckmann M, Collison A, Simpson JL, Kopp MV, Wark PAB, Smyth MJ, Yagita H, Matthaei KI, Hansbro N, Whitehead B, et al. Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease. Nat Med. 2007;13(11):1308\u201315.","journal-title":"Nat Med"},{"key":"786_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1465-9921-7-78","volume":"7","author":"GK Singhera","year":"2006","unstructured":"Singhera GK, Chan TS, Cheng JY, Vitalis TZ, Hamann KJ, Dorscheid DR. Apoptosis of viral-infected airway epithelial cells limit viral production and is altered by corticosteroid exposure. Respir Res. 2006;7:78.","journal-title":"Respir Res"},{"key":"786_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1046\/j.1365-3083.2000.00671.x","volume":"51","author":"O Halaas","year":"2000","unstructured":"Halaas O, Vik R, Ashkenazi A, Espevik T. Lipopolysaccharide induces expression of APO2 ligand\/TRAIL in human monocytes and macrophages. Scand J Immunol. 2000;51:244\u201350.","journal-title":"Scand J Immunol"},{"issue":"18","key":"786_CR10","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1091\/mbc.e15-04-0209","volume":"26","author":"J Gao","year":"2015","unstructured":"Gao J, Wang D, Liu D, Liu M, Ge Y, Jiang M, Liu Y, Zheng D. Tumor necrosis factor-related apoptosis-inducing ligand induces the expression of proinflammatory cytokines in macrophages and re-educates tumor-associated macrophages to an antitumor phenotype. Mol Biol Cell. 2015;26(18):3178\u201389.","journal-title":"Mol Biol Cell"},{"key":"786_CR11","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1191\/1352458505ms1222oa","volume":"11","author":"N Arbour","year":"2005","unstructured":"Arbour N, Rastikerdar E, McCrea E, Lapierre Y, Dorr J, Bar-Or A, Antel JP. Upregulation of TRAIL expression on human T lymphocytes by interferon b and glatiramer acetate. Mult Scler. 2005;11:652\u20137.","journal-title":"Mult Scler"},{"key":"786_CR12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/thoraxjnl-2011-200863","volume":"67","author":"EE McGrath","year":"2012","unstructured":"McGrath EE, Laurie A, Marriott HM, Mercer P, Cross SS, Arnold N, Singleton V, Thompson AA, Walmsley SR, Renshaw SA, Sabroe I, Chambers RC, Dockrell DH, Whyte MK. Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis. Throax. 2012;67:796\u2013803.","journal-title":"Throax"},{"issue":"11","key":"786_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/j.1440-1681.2009.05258.x","volume":"36","author":"A Collison","year":"2009","unstructured":"Collison A, Foster PS, Mattes J. Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses. Clin Exp Pharmacol Physiol. 2009;36(11):1049\u201353.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"786_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/5517","volume":"5","author":"H Walczak","year":"1999","unstructured":"Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med. 1999;5(2):157\u201363.","journal-title":"Nat Med"},{"issue":"5309","key":"786_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.276.5309.111","volume":"276","author":"G Pan","year":"1997","unstructured":"Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM. The receptor for the cytotoxic ligand TRAIL. Science. 1997;276(5309):111\u20133.","journal-title":"Science"},{"issue":"4","key":"786_CR16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jaci.2015.03.031","volume":"136","author":"AM Collison","year":"2015","unstructured":"Collison AM, Sokulsky LA, Sherrill JD, Nightingale S, Hatchwell L, Talley NJ, Walker MM, Rothenberg ME, Mattes J. TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis. J Allergy Clin Immunol. 2015;136(4):971\u201382.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"786_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1165\/rcmb.2013-0490OC","volume":"51","author":"A Collison","year":"2014","unstructured":"Collison A, Li J, Pereira de Siqueira A, Zhang J, Toop HD, Morris JC, Foster PS, Mattes J. Tumor necrosis factor-related apoptosis-inducing ligand regulates hallmark features of airways remodeling in allergic airways disease. Am J Respir Cell Mol Biol. 2014;51(1):86\u201393.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"786_CR18","first-page":"65","volume":"18","author":"MR Starkey","year":"2013","unstructured":"Starkey MR, Nguyen DH, Essilfie AT, KimRY HM, Collison AM, Yagita H, Foster PS, Horvat JC, Mattes J, Hansbro PM. Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal. Mucosal Immunol. 2013;18(10):65.","journal-title":"Mucosal Immunol"},{"issue":"8","key":"786_CR19","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1021\/bi901837h","volume":"49","author":"JL McConnell","year":"2010","unstructured":"McConnell JL, Watkins GR, Soss SE, Franz HS, McCorvey LR, Spiller BW, Chazin WJ, Wadzinski BE. Alpha4 is a ubiquitin-binding protein that regulates protein serine\/threonine phosphatase 2A ubiquitination. Biochemistry. 2010;49(8):1713\u20138.","journal-title":"Biochemistry"},{"key":"786_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/ng762","volume":"29","author":"A Trockenbacher","year":"2001","unstructured":"Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S. MID1, mutation in Opitz syndrome, encodes an ubiquitin ligase that targets phophatase 2A for degradation. Nat Genet. 2001;29:287\u201394.","journal-title":"Nat Genet"},{"issue":"29","key":"786_CR21","doi-asserted-by":"publisher","first-page":"24207","DOI":"10.1074\/jbc.M112.368613","volume":"287","author":"GR Watkins","year":"2012","unstructured":"Watkins GR, Wang N, Mazalouskas MD, Gomez RJ, Guthrie CR, Kraemer BC, Schweiger S, Spiller BW, Wadzinski BE. Monoubiquitination promotes calpain cleavage of the protein phosphatase 2A (PP2A) regulatory subunit alpha4, altering PP2A stability and microtubule-associated protein phosphorylation. J Biol Chem. 2012;287(29):24207\u201315.","journal-title":"J Biol Chem"},{"issue":"2","key":"786_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nm.3049","volume":"19","author":"A Collison","year":"2013","unstructured":"Collison A, Hatchwell L, Verrills N, Wark PA, de Siqueira AP, Tooze M, Carpenter H, Don AS, Morris JC, Zimmermann N, et al. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat Med. 2013;19(2):232\u20137.","journal-title":"Nat Med"},{"issue":"2","key":"786_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.pharmthera.2006.04.011","volume":"112","author":"AT Sim","year":"2006","unstructured":"Sim AT, Ludowyke RI, Verrills NM. Mast cell function: regulation of degranulation by serine\/threonine phosphatases. Pharmacol Ther. 2006;112(2):425\u201339.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"786_CR24","first-page":"L849","volume":"296","author":"TT Cornell","year":"2009","unstructured":"Cornell TT, Hinkovska-Galcheva V, Sun L, Cai Q, Hershenson MB, Vanway S, Shanley TP. Ceramide-dependent PP2A regulation of TNFalpha-induced IL-8 production in respiratory epithelial cells. Am J Physiol. 2009;296(5):L849\u201356.","journal-title":"Am J Physiol"},{"issue":"2","key":"786_CR25","doi-asserted-by":"publisher","first-page":"966","DOI":"10.4049\/jimmunol.166.2.966","volume":"166","author":"TP Shanley","year":"2001","unstructured":"Shanley TP, Vasi N, Denenberg A, Wong HR. The serine\/threonine phosphatase, PP2A: endogenous regulator of inflammatory cell signaling. J Immunol. 2001;166(2):966\u201372.","journal-title":"J Immunol"},{"key":"786_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0003-9861(03)00336-9","volume":"417","author":"V Miskolci","year":"2003","unstructured":"Miskolci V, Castro-Alcaraz S, Nguyen P, NVancura A, Davidson D, Vancurova I. Okadaic acid induces sustained activation of NFkB and degradation of the nuclear IkBa in human neutrophils. Arch Biochem Biophys. 2003;417:44\u201352.","journal-title":"Arch Biochem Biophys"},{"key":"786_CR27","doi-asserted-by":"publisher","unstructured":"Liu G, Cooley MA, Jarnicki AG, Hsu AC, Nair PM, Haw TJ, Fricker M, Gellatly SL, Kim RY, Inman MD et al. Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases. JCI Insight. 2016;1(9):e86380. \n                    https:\/\/doi.org\/10.1172\/jci.insight.86380\n                    \n                  .","DOI":"10.1172\/jci.insight.86380"},{"key":"786_CR28","doi-asserted-by":"crossref","unstructured":"Haw TJ, Starkey MR, Nair PM, Pavlidis S, Liu G, Nguyen DH, Hsu AC, Hanish I, Kim RY, Collison AM, et al. A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease. Mucosal Immunol. 2015.","DOI":"10.1038\/mi.2015.111"},{"issue":"49","key":"786_CR29","doi-asserted-by":"publisher","first-page":"17723","DOI":"10.1073\/pnas.0509235102","volume":"102","author":"DH Broide","year":"2005","unstructured":"Broide DH. Allergen-induced peribronchial fibrosis and mucus production mediated by I B kinase -dependent genes in airway epithelium. Proc Natl Acad Sci. 2005;102(49):17723\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"786_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","volume":"89","author":"RL Francois Denizot","year":"1986","unstructured":"Francois Denizot RL. Rapid colorimetric assay for cell growth and survival, modifications to the tetrazolium dy procedure giving improved sensitivity and reliability. J Immunol Methods. 1986;89:271\u20137.","journal-title":"J Immunol Methods"},{"issue":"1","key":"786_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1):55\u201363.","journal-title":"J Immunol Methods"},{"issue":"1","key":"786_CR32","doi-asserted-by":"publisher","first-page":"L89","DOI":"10.1152\/ajplung.00200.2016","volume":"312","author":"JL Girkin","year":"2017","unstructured":"Girkin JL, Hatchwell LM, Collison AM, Starkey MR, Hansbro PM, Yagita H, Foster PS, Mattes J. TRAIL signaling is proinflammatory and proviral in a murine model of rhinovirus 1B infection. Am J Physiol Lung Cell Mol Physiol. 2017;312(1):L89\u2013L99.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"786_CR33","first-page":"02016","volume":"00151","author":"LA Sokulsky","year":"2016","unstructured":"Sokulsky LA, Collison AM, Nightingale S, Le Fevre A, Percival E, Starkey MR, Hansbro PM, Foster PS, Mattes J. TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen driven eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol. 2016;00151:02016 ajpgi.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"786_CR34","first-page":"552","volume":"7","author":"KM Akram","year":"2014","unstructured":"Akram KM, Lomas NJ, Forsyth NR, Spiteri MA. Alveolar epithelial cells in idiopahtic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53. Int J Clin Exp Pathol. 2014;7(2):552\u201364.","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"786_CR35","first-page":"1238","volume":"196","author":"HB Schiller","year":"2017","unstructured":"Schiller HB, Mayr CH, Leuschner G, Strunz M, Staab-Weiinitz C, Preisendorfer S, Eckes B, Moinzadeh P, Krieg T, Schwartz DA, Hatz RA, Behr J, Mann M, Eickelberg O. Deep proteome progiling reveals common prevalence of MZB1-positive plasma B cells in human lung and skin fibrosis. AJRCCM. 2017;196(10):1238\u201340.","journal-title":"AJRCCM"},{"key":"786_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/CLEP.S54815","volume":"5","author":"B Ley","year":"2013","unstructured":"Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol. 2013;5:483\u201392.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"786_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","volume":"15","author":"KF Budden","year":"2017","unstructured":"Budden KF, Gellatly SL, Wood DL, Cooper MA, Morrison M, Hugenholtz P, Hansbro PM. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017;15(1):55\u201363.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"786_CR38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/mi.2013.65","volume":"7","author":"MR Starkey","year":"2014","unstructured":"Starkey MR, Nguyen DH, Essilfie AT, Kim RY, Hatchwell LM, Collison AM, Yagita H, Foster PS, Horvat JC, Mattes J, et al. Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease. Mucosal Immunol. 2014;7(3):478\u201388.","journal-title":"Mucosal Immunol"},{"issue":"2","key":"786_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","volume":"33","author":"J Chun","year":"2010","unstructured":"Chun J, Hartung HP. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol. 2010;33(2):91\u2013101.","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"786_CR40","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ana.22426","volume":"69","author":"JA Cohen","year":"2011","unstructured":"Cohen JA, Chun J. Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. Ann Neurol. 2011;69(5):759\u201377.","journal-title":"Ann Neurol"},{"issue":"2","key":"786_CR41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","volume":"6","author":"DA Lynch","year":"2018","unstructured":"Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, Goldin JG, Hansell DM, Inoue Y, Johkoh T, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner society white paper. Lancet Respir Med. 2018;6(2):138\u201353.","journal-title":"Lancet Respir Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0786-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0786-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0786-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T19:07:24Z","timestamp":1581016044000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0786-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0786-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"21 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from individual subjects, and all the studies were approved by the Medical Ethics Committee of the Second Affiliated Hospital of Jilin University, Changchun, Jilin, P.R. China.The Animal Care and Ethics Committee of the University of Newcastle, Australia approved all animal experiments, which were conducted and reported in accordance with the ARRIVE guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable to this publication","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.C. is currently acting as an Associate Editor for BMC Pulmonary Medicine. J.M. is currently acting as a Section Editor for BMC Pulmonary Medicine. The authors have no other competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"31"}}